SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Bristol-Myers (BMY)

BMY RSS Feed
Add BMY Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 8/23/2017 3:44:41 PM - Followers: 34 - Board type: Free - Posts Today: 0
BMY
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BMY News: Bristol-Myers Squibb & Pfizer to Highlight Commitment to Reducing the Risk of Stroke Caused by Non-Valvular Atrial Fibrillati... 08/18/2017 06:59:00 AM
BMY News: Bristol-Myers Squibb Announces Topline Results from CheckMate -214, a Phase 3 Study of Opdivo in Combination with Yervoy in I... 08/15/2017 04:30:00 PM
BMY News: Bristol-Myers Squibb to Acquire IFM Therapeutics to Strengthen Oncology Pipeline Focus on Innate Immunity 08/03/2017 04:00:00 PM
BMY News: Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) in MSI-H or dMMR Metastatic Colorectal Cancer That Has Prog... 08/01/2017 06:59:00 AM
BMY News: Bristol-Myers Squibb & Clovis Oncology Announce a Broad Clinical Collaboration to Evaluate Combination of Opdivo (Nivolumab) ... 07/31/2017 06:59:00 AM
PostSubject
#614   Another up day for BMY on low low Johnny_C 08/23/17 03:44:41 PM
#613   Up quite a bit on no news and Johnny_C 08/23/17 11:58:43 AM
#612   Hadn't paid attention to the low volume until chmcnfunds 08/23/17 09:34:58 AM
#611   Almost all big pharma up big and virtually Johnny_C 08/22/17 03:27:18 PM
#610   All big pharma up big today! BMY Johnny_C 08/22/17 11:45:34 AM
#609   They say 40% upside possible, that is on Johnny_C 08/18/17 12:46:06 PM
#608   Bristol-Myers Squibb's (BMY) Nivolumab Receives FDA Orphan Designation chmcnfunds 08/18/17 09:16:29 AM
#607   https://seekingalpha.com/article/4099450-bristol-myers-squibb-combination-treatm Inoviorulez 08/16/17 06:22:42 PM
#606   BMY’s stock is too cheap, says Barron’s: DewDiligence 08/16/17 04:06:44 PM
#605   Bristol-Myers shares sink after another setback for its chmcnfunds 08/16/17 10:47:30 AM
#604   Glad the pps is recovering pre-market. While disappointing chmcnfunds 08/16/17 09:19:39 AM
#603   Musings on Opdivo/Yervoy results in RCC: #msg-133869270. DewDiligence 08/15/17 09:00:36 PM
#602   https://seekingalpha.com/article/4099033-bristol-myers-squibb-hiv-franchise-neve Inoviorulez 08/15/17 07:00:02 PM
#601   So much for $58. chmcnfunds 08/15/17 04:40:44 PM
#600   Consensus Ratings for Bristol-Myers Squibb Company (NYSE:BMY) (How chmcnfunds 08/10/17 09:09:48 AM
#599   Nice find. Rumors rumors rumors. Johnny_C 08/10/17 08:13:51 AM
#598   Buy out rumors/analyst comment: chmcnfunds 08/08/17 12:14:04 PM
#597   Bullish SA article: chmcnfunds 08/07/17 09:14:09 AM
#596   https://www.nytimes.com/2017/08/03/us/politics/fda-senate-experimental-drugs-ter north40000 08/04/17 09:45:05 PM
#595   Looks like another good oncology drug. Buying early Johnny_C 08/03/17 08:14:39 PM
#594   Still think they are a target. PFE CEO Johnny_C 08/03/17 05:51:41 PM
#593   BMY acquires—(private)—I-O company, IFM, for $300M up-front &$1.01B DewDiligence 08/03/17 04:08:39 PM
#592   The settlement covers all indications, as far as DewDiligence 08/03/17 10:38:39 AM
#591   https://seekingalpha.com/article/4093572-bristol-myers-looking-maintain-lead-imm Inoviorulez 08/02/17 05:04:57 PM
#590   Not sure the range of indications covered by chmcnfunds 08/02/17 03:04:19 PM
#589   Perhaps you know whether either MRK or BMY north40000 08/02/17 02:48:03 PM
#588   Bristol-Myers: Looking To Maintain Lead In Immunotherapy chmcnfunds 08/02/17 08:24:05 AM
#587   BMY now selling its state of the art Johnny_C 08/02/17 08:15:53 AM
#586   Good call, that is exactly what was stated Johnny_C 08/01/17 11:19:16 AM
#585   Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) chmcnfunds 08/01/17 07:21:53 AM
#584   I was talking to a friend last night Johnny_C 07/31/17 03:43:59 PM
#583   Understood -- posted it as a reminder and chmcnfunds 07/31/17 03:31:05 PM
#582   That's good news, but all it really means Johnny_C 07/31/17 03:25:37 PM
#581   U.S. Food and Drug Administration Accepts for Priority chmcnfunds 07/31/17 11:10:40 AM
#580   Bristol-Myers and Clovis to evaluate Opdivo/Rubraca combo in chmcnfunds 07/31/17 10:07:14 AM
#579   Bristol-Myers Squibb (BMY) Q2 2017 Results - Earnings chmcnfunds 07/28/17 09:13:34 AM
#578   Cancer drug war heats up as Big Pharma chmcnfunds 07/27/17 10:41:27 AM
#577   Seeking Alpha should have a transcription of the chmcnfunds 07/27/17 09:58:40 AM
#576   Bummer, win some lose some. Options will Johnny_C 07/27/17 09:53:41 AM
#575   This seems to be the story, not the chmcnfunds 07/27/17 08:31:49 AM
#574   I agree with you, rumors are usually true Johnny_C 07/26/17 10:40:40 AM
#573   As I've posted previously, a large-scale buyout (of DewDiligence 07/26/17 10:20:52 AM
#572   Earnings tomorrow, should be interesting. Looks like buyout Johnny_C 07/26/17 09:17:01 AM
#571   Bristol-Myers Squibb’s ORENCIA® (abatacept) Receives Second European Commission chmcnfunds 07/26/17 08:12:06 AM
#570   Opdivo sBLA allowing 4-week dosing interval for all DewDiligence 07/24/17 04:50:48 PM
#569   U.S. Food & Drug Administration Expands Approval of chmcnfunds 07/24/17 09:30:07 AM
#568   Very long time and notable director < http://www.reuters.com/finance/stocks/offi chmcnfunds 07/17/17 10:13:58 AM
#567   Long time Director leaving! Johnny_C 07/17/17 09:52:09 AM
#566   Earnings soon, that could bring higher levels... still Johnny_C 07/14/17 06:34:07 AM
#565   Jefferies new rating? Folks realizing the drop was chmcnfunds 07/13/17 11:42:31 AM
PostSubject